Neurovascular Embolization Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Neurovascular Embolization Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Neurovascular Embolization Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Neurovascular Embolization Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Neurovascular embolization devices are used to treat abnormalities in blood vessels in the brain, namely, brain aneurysms and arteriovenous malformations (AVM). These devices occlude or prevent blood flow to unwanted vessel malformations.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Neurovascular Embolization Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Neurovascular Embolization Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Neurovascular Embolization Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Neurovascular Embolization Devices Overview
3 Products under Development
3.1 Neurovascular Embolization Devices - Pipeline Products by Stage of Development
3.2 Neurovascular Embolization Devices - Pipeline Products by Segment
3.3 Neurovascular Embolization Devices - Pipeline Products by Territory
3.4 Neurovascular Embolization Devices - Pipeline Products by Regulatory Path
3.5 Neurovascular Embolization Devices - Pipeline Products by Estimated Approval Date
TRUFILL n-BCA Liquid Embolic System - Chronic Subdural Hematoma - Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas with TRUFILL n-BCA
F2 Cerebral Embolic Filter - A Prospective, Single-Arm, Multicenter Feasibility Trial to Evaluate the Safety and Performance of the F2 Filter and Delivery System Used for Embolic Protection During Transcatheter Aortic Valve Replacement
F2 Cerebral Embolic Filter - A Prospective, Single-arm, Multicenter Feasibility Trial to Evaluate the Safety and Performance of the F2 Filter and Delivery System Used for Embolic Protection During Transcatheter Aortic Valve Replacement
F2 Cerebral Embolic Filter - A Prospective, Single-Arm, Single Center Feasibility Trial to Evaluate the Safety and Performance of the F2 Filter and Delivery System Used for Embolic Protection During Transcatheter Aortic Valve Replacement
Artisse Intrasaccular Device - Artisse™ Intrasaccular Device IDE
Onyx Liquid Embolic System - Middle Meningeal Arterial Embolization - Managing Non-acute Subdural Hematoma Using Liquid Materials: A Chinese Randomized Trial of MMA Treatment
Onyx Liquid Embolic System - Middle Meningeal Arterial Embolization - The Onyx Trial for the Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma (OTEMACS)
Tubridge Plus Flowdiverting Stent - Prospective, Multi-Center, Open-Label, Single-Arm Registration Trial Of The Tubridge Plus For The Treatment Of Wide-Necked Intracranial Aneurysms
Flow Diverter Stent System - A Prospective, Multi-center, Single Arm Clinical Study to Evaluate the Safety and Effectiveness of the Flow Diverter Stent System in the Treatment of Cerebral Aneurysms
Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
Flow Diverter Stent - Product Status
Flow Diverter Stent - Product Description
Radiopaque Liquid Embolization Device - Product Status